Abortion pill mifepristone is banned or restricted in some states despite Supreme Court ruling

Abortion pill mifepristone is banned or restricted in some states despite Supreme Court ruling


In this photo illustration, packages of Mifepristone tablets are displayed at a family planning clinic on April 13, 2023 in Rockville, Maryland.

Anna Moneymaker | Getty Images

The abortion pill mifepristone is either banned or restricted to varying degrees in 27 states despite a Supreme Court decision that — for now — maintains Food and Drug Administration regulations allowing easy access to the medication.

The Supreme Court, acting on an emergency basis, last week blocked lower federal court orders that had imposed severe restrictions on mifepristone even in some states where abortion remains legal.

The ruling stemmed from a lawsuit against the FDA by a coalition of doctors who oppose abortion. That group wants to force the agency to pull mifepristone from the market entirely. The Biden administration is opposing that effort.

The U.S. 5th Circuit Court of Appeals is now scheduled to hear oral arguments in the case on May 17.

The side that loses at the appeals courts is certain to ask the Supreme Court to take the case to make a final determination on the legality of the FDA rules.

The FDA rules upheld by the Supreme Court on Friday for several years have allowed women to obtain a mifepristone prescription through a telehealth appointment and to receive the medication by mail.

Patients previously were required by FDA to obtain mifepristone in-person from a health-care provider or take the medication under their supervision.

While the Supreme Court’s decision at least temporarily maintains access to mifepristone in states that support broad access to abortion, it will have less or no impact in conservative states that banned the procedure since last summer, when the high court overturned the half-century-old federal constitutional right to abortion.

CNBC Health & Science

Read CNBC’s latest global health coverage:

Mifepristone will remain largely unavailable in 13 states that have completely banned abortion.

Those states are Alabama, Arkansas, Idaho, Kentucky, Louisiana, Mississippi, Missouri, North Dakota, Oklahoma, South Dakota, Tennessee, Texas and West Virginia, according to the Guttmacher Institute, a nonprofit group that supports abortion access.

All of those states have exceptions that allow abortion when the woman’s life is in danger.

And Idaho, West Virginia and North Dakota have exceptions for pregnancies that result from rape and incest, although in North Dakota that exception applies only through the sixth week of pregnancy.

Fourteen other states have restrictions on mifepristone that go beyond the FDA regulations temporarily upheld by the Supreme Court.

Those states require women to obtain the pill from a doctor.

Those states are: Alaska, Arizona, Florida, Georgia, Indiana, Iowa, Michigan, Nebraska, Nevada, North Carolina, Ohio, Pennsylvania, South Carolina and Utah.

Florida, Georgia and Ohio ban abortion after six weeks before many women know they are pregnant.

Mifepristone is FDA-approved to terminate an early pregnancy up to the 10th week of pregnancy.

There are pending federal lawsuits in North Carolina and West Virginia that seek to overturn those states’ mifepristone restrictions.



Source

Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers
Health

Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers

U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with Pfizer to lower Medicaid drug prices in the Oval Office of the White House on September 30, 2025 in Washington, DC. Win Mcnamee | Getty Images President Donald Trump’s long-awaited threat to impose pharmaceutical tariffs may not […]

Read More
Healthy Returns: Pfizer’s new obesity bet, Metsera, releases encouraging data on lead drug
Health

Healthy Returns: Pfizer’s new obesity bet, Metsera, releases encouraging data on lead drug

Thomas Fuller | SOPA Images | Lightrocket | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Pfizer‘s newest bet on obesity is already showing promise.  The company last week said it would buy […]

Read More
Trump, Pfizer to announce agreement to lower Medicaid drug prices
Health

Trump, Pfizer to announce agreement to lower Medicaid drug prices

U.S. President Donald Trump speaks during a press conference in the Roosevelt Room at the White House in Washington, D.C., U.S., May 12, 2025. Nathan Howard | Reuters President Donald Trump on Tuesday will announce an agreement with Pfizer to voluntarily sell its medications for less, as his administration pushes to link U.S. drug prices […]

Read More